Resultado a longo prazo de tratamento conservador de rabdomiossarcoma vesical infantil: relato de caso/Long term result of conservative treatment of bladder rhabdomyosarcoma in children: case report
Main Article Content
Abstract
Os tumores vesicais ocorrem mais frequentemente entre a quinta e sétima décadas de vida, sendo raros antes dos 40 anos de idade. O rabdomiossarcoma é um tumor embrionário raro originado do tecido muscular esquelético, que, quando localizado no trato geniturinário, se manifesta com hematúria e sintomas urinários obstrutivos. É um tumor que acomete principalmente a faixa etária infantil. Por se tratar de um tumor muito agressivo geralmente necessita de tratamento cirúrgico, com ressecções parciais e até mesmo remoção completa de grande parte do trato geniturinário baixo. Será relatado um caso de rabdomiossarcoma vesical em criança de 5 anos, cujo tratamento sem cirurgia foi curativo e que com acompanhamento a longo prazo não houve recorrência tumoral.
Palavras chaves: Bexiga, rabdomiossarcoma, tratamento conservador
ABSTRACT
The bladder tumors occur most often between the fifth and seventh decades of life, being rare before forty. The embryonal rhabdomyosarcoma is a rare tumor originating from the skeletal muscle tissue, which, when located in the genitourinary tract, manifested with haematuria and urinary obstruction. This tumor is more common in the childhood. It’s a very aggressive tumor and usually requires surgical treatment which partial resection and even the complete removal of much of the lower urinary tract. This is a report of one case of bladder rhabdomyosarcoma in a 5 years old child, whose treatment was curative without surgery, and in the long-term following there was no tumor recurrence.
Keywords: Bladder, rhabdomyosarcoma, conservative treatment
Article Details
Authors maintain copyright and grant the HSJ the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International , allowing their sharing, recognizing the authorship and initial publication in this journal.
Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.
Also, the AUTHOR is informed and consents that the HSJ can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.